Author:
Shivakumar Prakruthi,Sunil Shettigar Kavitha
Abstract
Tuberculosis (TB) is caused by a single infectious agent, Mycobacterium tuberculosis, and a public health concern due to increased cases of drug-resistance and high mortality rates. Rapid identification of tuberculosis is necessary for its early treatment and to prevent the emergence of drug-resistant strains. For effective management of patients, rapid, cost-effective, and point-of-care (POC) diagnostic methods are required. The commonly used screening and identification methods are clinical examination, radiography, sputum smear microscopy, culture method, serological method, and tuberculin skin test. In addition, several molecular methods such as NAAT based GeneXpert, loop-mediated isothermal amplification (LAMP), line probe assay (LPA), whole genome sequencing (WGS) and other non-invasive methods of lateral flow urine lipoarabinomannan assay (LF-LAM) and eNose assays are developed. Sputum smear microscopy, Xpert MTB/RIF, and LED-Fluorescence microscopy (LED-FM) are the preferred methods to use in peripheral laboratories. The non-invasive methods of tuberculosis diagnosis are more beneficial in patients from whom collecting sputum sample is difficult particularly in children and HIV co-infected patients. Molecular methods can simultaneously identify the pathogen, M. tuberculosis, and mutations in drug-resistance genes. Even though, many advanced methods are currently available, accurate and affordable diagnostic method for tuberculosis is still challenging. Here, we review and highlight the uses and challenges of currently available conventional and advanced diagnostic methods of tuberculosis screening and diagnosis.
Reference94 articles.
1. Wirth T, Hildebrand F, Allix-Beguec C, Wolbeling F, Kubica T, Kremer K, et al. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathogens. 2008;4(9):e1000160. DOI: 10.1371/journal.ppat.1000160
2. World Health Organization. Multidrug-Resistant Tuberculosis (MDR-TB)-2015. UPDATE. Geneva, Switzerland: WHO; 2015
3. Suliman S, Pelzer PT, Shaku M, Rozot V, Mendelsohn SC. Meeting report: Virtual global forum on tuberculosis vaccines, 20-22 April 2021. Vaccine. 2021;39(50):7223-7229. DOI: 10.1016/j.vaccine.2021.08.094 Epub 2021 Sep 15
4. Gill CM, Dolan L, Piggott LM, McLaughlin AM. New developments in tuberculosis diagnosis and treatment. Breathe. 2022;18(1):210149. DOI: 10.1183/20734735.0149-2021 Epub 2021 Mar 8
5. World Health Organization. Tuberculosis diagnostics. Geneva, Switzerland: WHO; 2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献